Administration of anti-inflammatory and immunosuppressive drugs or angiotensin converting enzyme inhibitors may suppress myocardial inflammation and fibrosis and thus decrease vulnerability to ventricular arrhythmias and sudden cardiac death [1, 29]. Here, ACE is linked to Ventricular arrhythmia.